
TSE:WEED
This summary was created by AI, based on 1 opinions in the last 12 months.
Canopy Growth Corp. (symbol: WEED-T) has faced significant scrutiny from industry experts regarding its investment viability. A prominent review indicates that the company has demonstrated weak returns on capital, suggesting systemic issues in its financial management and overall business strategy. The investor's sentiment reflects a belief that excessive capital has been invested without proportions of return, leading to a loss of value. There is a clear call for major consolidation within the cannabis sector and improvements in the regulatory landscape, which are seen as critical for restoring investor confidence. These expert opinions paint a cautious picture, where serious reevaluation and restructuring are considered necessary before it becomes a viable investment opportunity.
The leader in marijuana. They are going to be an aggressive acquirer. Have done at least 3 that he can think of, so will be one of the companies that will survive. There is no doubt the industry is going to grow and it is going to grow fast. There are going to be winners and losers, and thinks this is going to be one of the winners. If you like the space, this is probably the name to own.
It is very difficult to make a fundamental argument for this marijuana company. It looks like the Canadian government is going to legalize marijuana, making good on their election promise. However, from an investment standpoint, he has a tough time valuing the market size. Technically, he would like to see the company do a nice big U and get back up towards $18, consolidate, and then move on towards new highs. To initiate a position, these levels are relatively good, but speculative and shouldn’t be a massive percentage of one’s portfolio.
This stock can be really volatile. Hit a new 52 week high today, and then pulled back about 25%. If buying, don’t do it in one big chunk. This is the biggest of all the Canadian licensed producers. They have about 20% of the patients in Canada, and are starting to look at diversifying out internationally. This might turn out to be the global leader in medical and recreational marijuana. The sector has run up so much, and they still don’t even have earnings or positive cash flow.
There is a lot of heat in these stocks, and they have obviously done really, really well. Thinks they are very hyped at the moment. The best of these stocks, will ultimately be acquired. If you are looking for upside with a lot of speculation, this may be a category to look at, but not the kind of thing you want to risk your savings on.
Canopy Growth (CGC-T) or Aurora Cannabis (ACB-X)? He does not want to recommend either, but would take the larger Canopy over Aurora. This has an $820 million market cap valuation, and if they are lucky will have $40 million in sales next year. There is no rational way of evaluating these on any fundamental basis, so you are buying them on the anticipation that someone else is going to pay more. A very, very dangerous game.
There is some forward thinking by analysts and investors that the recreational use of marijuana is going to become legal, and companies like this will be well positioned. If that does happen, there will be another leg up on these kinds of stocks. Typically, in these very early stage industries, after the fundamentals play out and the dust settles, investors will start to question how many customers they will actually serve and how much money what they actually make. It is almost too early to do that, so stocks are going up and up on very little fundamental analysis by anybody, just on speculation. If you are in this, now would be a good time to take some profits.
A market cap of about $850 million, which is really high given that they don’t have any sort of net income to speak of. He is leery of companies that are too dependent on regulations or governments. Given that the stock has doubled in relatively short order, if you are sitting on a good gain you may want to take some risk off the table. Speculative.
The positive effect is when Trudeau announced he was going to legalize marijuana. However, we all know that when government gets involved, prices, supply, profits get controlled, and the opportunity suddenly shrinks down less than what you initially thought. He thinks it is going to be a collision case in what happens.
It is really odd that it sat around for June/Jul, then we had upside, so there must have been a good story breaking. This stock is really driven by news and policy changes. You are going to see a lot of fits and starts. You would want to see it not come back to the level of last November. A lot of the indicators are really elevated, suggesting it wants to correct. It may pause, or fall in price, or a combination.
Not a big fan of the sector. The way the structure was set up in Canada with medicinal marijuana, they are going to have a very tough time being competitive in the long-term. Especially if there is de-legalization of marijuana. When you start to get recreational use, constraints that have been put around medical marijuana companies are not going to make them very economic.